跳至主要内容
临床试验/NCT05817292
NCT05817292已完成不适用

Characterization of the Vaginal Microbiota in Fertile Age: Correlations Clinical and Pathogenetic Correlations Among Gynecological Disorders.

Universita degli Studi di Catania1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Microbiota

研究概览

简要总结

Characterization of the vaginal microbiota of women under fertile age and study of correlations with gynecological disorders

详细描述

The study aimed to characterize, in women under fertile age, the composition and dynamics of the vaginal microbiota as well as to in-depth study correlations among microbiota and gynecological disorders

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age between 18 and 45 years;
  • Presence of at least one vaginal sign or symptom (leucorrhoea, burning, itching, and subjective vaginal discomfort);
  • Presence of at least 3 Amsel criteria;
  • Nugent score ≥ 7;
  • lactobacillary grade ≥ 2 (LBG) (according to Donders classification);
  • presence of blastospores and/or pseudohyphae evaluated by fresh mount microscopy

排除标准

  • Age < 18 years;
  • Nugent score < 7;
  • presence of sexually transmitted disease due to Chlamydia, Neisseria gonorrhoeae, or Trichomonas vaginalis as well as specific cervico-vaginitis or severe vulvovaginal symptoms related to acute candidiasis;
  • Clinically apparent herpes simplex infection;
  • Human papillomavirus or human immunodeficiency virus infections;
  • Use of antibiotic, antifungal, probiotic, or immunosuppressive drugs during the past four weeks;
  • Use of vaginal contraceptives;
  • Pregnancy or breastfeeding, chronic diseases, neoplastic disease, diabetes, genital tract bleeding)

结局指标

主要结局

Microbiota

时间窗: Baseline; end of the treatment (10 days) ; wash-out (4 weeks)

Change from baseline in the composition of the vaginal microbiota with the increase of the cell density of lactobacilli (at least 3 log units) and decrease of pathogens (at least 2 log units) at the end of the treatment (10 days) and during the wash-out period (4 weeks after the end of the treatment)

Signs

时间窗: Baseline; end of the treatment (10 days) ; wash-out (4 weeks)

Change from baseline of the Nugent score with values between 0 and 3 at the end of the treatment (10 days) and during the wash-out period (4 weeks after the end of the treatment)

Symptomatology

时间窗: Baseline; end of the treatment (10 days) ; wash-out (4 weeks)

Change from baseline of vulvovaginal erythema/edema, vulvar discomfort, burning, and itching

次要结局

  • Wellbeing(Baseline; end of the treatment (10 days) ; wash-out (4 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Agnese Maria Chiara Rapisarda

doctor

Universita degli Studi di Catania

研究点 (1)

Loading locations...

相似试验